Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical nano-liposomal amphotericin B for cutaneous leishmaniasis (L. major)
IRCT201510161475N10Phase 3Completed
- Sponsor
- Iran Nanotechnology Initiative Council
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of amphotericin b in cutaneous leishmaniasis (CL), sponsored by Iran Nanotechnology Initiative Council. Started Oct 2015; status: completed.
02
Drugs
amphotericin b
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT201510161475N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201510161475N10.